Edges in Network
Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
Node | SLC25A31 |
Upstream (Parents) |
---|
(<<) CHD2 → SLC25A31 |
(<<) TRPC5 → SLC25A31 |
(<<) ACE → SLC25A31 |
(<<) WSCD2 → SLC25A31 |
(<<) BCAP29 → SLC25A31 |
(<<) GCNT4 → SLC25A31 |
(<<) NCAN → SLC25A31 |
(<<) C22orf31 → SLC25A31 |
(<<) SCRT1 → SLC25A31 |
(<<) RFX3 → SLC25A31 |
(<<) NFKBIB → SLC25A31 |
(<<) MMP25 → SLC25A31 |
Downstream (Children) |
---|
SLC25A31 → CHD2 (>>) |
SLC25A31 → GCNT4 (>>) |
SLC25A31 → OR1A1 (>>) |
SLC25A31 → SCRT1 (>>) |
SLC25A31 → RBMY1J///RBMY1E///RBMY1D///RBMY1B///RBMY1F///RBMY3AP///RBMY1H///RBMY1A1 (>>) |
SLC25A31 → MMP25 (>>) |